Study of a new medicine for healthy volunteers
Part of Lungs & breathing clinical trials.
This study tests a new medicine called MN-08 in healthy volunteers to see how safe it is and how the body handles it. It helps find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are a non-smoker and have not used nicotine products in the past 3 months
- Your body mass index (BMI) is between 18 and 30
- You are in good health with no major medical conditions
- You agree to use birth control during the study and for 90 days after
- You have not used any prescription or over-the-counter medications recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called NS-863 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. The study aims to see if the drug can improve symptoms and exercise ability.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests a new medicine in healthy people to see how it is absorbed and broken down by the body, and to make sure it is safe. If you join, you will take the medicine under fasting conditions and have regular blood tests.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.